Cited 153 times in
Gallic acid suppresses lipopolysaccharide-induced nuclear factor-kappaB signaling by preventing RelA acetylation in A549 lung cancer cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 최경철 | - |
dc.contributor.author | 권승현 | - |
dc.contributor.author | 윤호근 | - |
dc.contributor.author | 이재면 | - |
dc.contributor.author | 김미정 | - |
dc.date.accessioned | 2015-04-24T17:28:14Z | - |
dc.date.available | 2015-04-24T17:28:14Z | - |
dc.date.issued | 2009 | - |
dc.identifier.issn | 1541-7786 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/105459 | - |
dc.description.abstract | Although multiple studies have revealed that gallic acid plays an important role in the inhibition of malignant transformation, cancer development, and inflammation, the molecular mechanism of gallic acid in inflammatory diseases is still unclear. In this study, we identified gallic acid from Rosa rugosa as a histone acetyltransferase (HAT) inhibitor with global specificity for the majority of HAT enzymes, but with no activity toward epigenetic enzymes including sirtuin (silent mating type information regulation 2 homologue) 1 (S. cerevisiae), histone deacetylase, and histone methyltransferase. Enzyme kinetic studies indicated that gallic acid uncompetitively inhibits p300/CBP-dependent HAT activities. We found that gallic acid inhibits p300-induced p65 acetylation, both in vitro and in vivo, increases the level of cytosolic IkappaBalpha, prevents lipopolysaccharide (LPS)-induced p65 translocation to the nucleus, and suppresses LPS-induced nuclear factor-kappaB activation in A549 lung cancer cells. We have also shown that gallic acid treatment inhibits the acetylation of p65 and the LPS-induced serum levels of interleukin-6 in vivo. Importantly, gallic acid generally inhibited inflammatory responses caused by other stimuli, including LPS, IFN-gamma, and interleukin-1beta, and further downregulated the expression of nuclear factor-kappaB-regulated antiapoptotic genes. These results show the crucial role of acetylation in the development of inflammatory diseases. | - |
dc.description.statementOfResponsibility | open | - |
dc.format | application/pdf | - |
dc.relation.isPartOf | MOLECULAR CANCER RESEARCH | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Acetylation/drug effects | - |
dc.subject.MESH | Animals | - |
dc.subject.MESH | Apoptosis/drug effects | - |
dc.subject.MESH | Cell Line, Tumor | - |
dc.subject.MESH | Cell Survival/drug effects | - |
dc.subject.MESH | Cell Survival/genetics | - |
dc.subject.MESH | E1A-Associated p300 Protein/metabolism | - |
dc.subject.MESH | Enzyme Inhibitors/pharmacology | - |
dc.subject.MESH | Gallic Acid/pharmacology* | - |
dc.subject.MESH | Gene Expression Regulation, Neoplastic/drug effects | - |
dc.subject.MESH | Histone Acetyltransferases/antagonists & inhibitors | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Inflammation/pathology | - |
dc.subject.MESH | Lipopolysaccharides/pharmacology* | - |
dc.subject.MESH | Lung Neoplasms/enzymology | - |
dc.subject.MESH | Lung Neoplasms/genetics | - |
dc.subject.MESH | Lung Neoplasms/metabolism* | - |
dc.subject.MESH | Lung Neoplasms/pathology* | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Mice | - |
dc.subject.MESH | Mice, Inbred BALB C | - |
dc.subject.MESH | Rosaceae/chemistry | - |
dc.subject.MESH | Signal Transduction/drug effects* | - |
dc.subject.MESH | Transcription Factor RelA/metabolism* | - |
dc.title | Gallic acid suppresses lipopolysaccharide-induced nuclear factor-kappaB signaling by preventing RelA acetylation in A549 lung cancer cells | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Microbiology (미생물학) | - |
dc.contributor.googleauthor | Kyung-Chul Choi | - |
dc.contributor.googleauthor | Yoo-Hyun Lee | - |
dc.contributor.googleauthor | Myung Gu Jung | - |
dc.contributor.googleauthor | Seung Hyun Kwon | - |
dc.contributor.googleauthor | Mi-Jeong Kim | - |
dc.contributor.googleauthor | Woo Jin Jun | - |
dc.contributor.googleauthor | Jeongmin Lee | - |
dc.contributor.googleauthor | Jae Myun Lee | - |
dc.contributor.googleauthor | Ho-Geun Yoon | - |
dc.identifier.doi | 10.1158/1541-7786.MCR-09-0239 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A04035 | - |
dc.contributor.localId | A00227 | - |
dc.contributor.localId | A02625 | - |
dc.contributor.localId | A03071 | - |
dc.relation.journalcode | J02253 | - |
dc.identifier.eissn | 1557-3125 | - |
dc.identifier.pmid | 19996305 | - |
dc.contributor.alternativeName | Choi, Kyung Chul | - |
dc.contributor.alternativeName | Kwon, Seung Hyun | - |
dc.contributor.alternativeName | Yoon, Ho Geun | - |
dc.contributor.alternativeName | Lee, Jae Myun | - |
dc.contributor.affiliatedAuthor | Choi, Kyung Chul | - |
dc.contributor.affiliatedAuthor | Kwon, Seung Hyun | - |
dc.contributor.affiliatedAuthor | Yoon, Ho Geun | - |
dc.contributor.affiliatedAuthor | Lee, Jae Myun | - |
dc.citation.volume | 7 | - |
dc.citation.number | 12 | - |
dc.citation.startPage | 2011 | - |
dc.citation.endPage | 2021 | - |
dc.identifier.bibliographicCitation | MOLECULAR CANCER RESEARCH, Vol.7(12) : 2011-2021, 2009 | - |
dc.identifier.rimsid | 44278 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.